CRITERIA

WFD typically invests between $2 million and $15 million in therapeutic, diagnostic or drug delivery technologies with strong intellectual property rights and exceptional market potentials. WFD invests in ventures at any stage, and will assist with prototype development, intellectual property and licensing strategies, clinical trials (US and OUS), regulatory filings (510(k), PMA and drug/device combinations), system and physician economics, reimbursement, distribution strategies and sales management.